Published August 29, 2026
This one came across our desk from a news source on 2026-09-02 — 'GLORY-2: once-weekly mazdutide beat placebo on weight loss…'. Our job here is the translation layer: what the headline means in protein, fiber and fat terms, and what stays unchanged on your plate no matter what the news says.
This story is on our radar. We cover GLP-1 news by checking the source and translating only the food-relevant part into the site's usual terms — protein, fiber and fat. Where a story makes food claims, the USDA data is the referee.
Strip the headline off almost any GLP-1 story and the same three variables sit underneath: protein for muscle, fat as the nausea trigger, fiber and water for regularity. Those are the exact axes this site scores every food on, which is why news and our scored thresholds tend to agree.
A news story about GLP-1s — whatever the angle — rarely changes the food math. It can change which nutrients get attention, which is why this site's verdict labels exist: they are a stable reference that works regardless of the news cycle.
A clear boundary keeps this site useful: it answers what is in the food, and it stops there. Whether a headline applies to your dose or your treatment is a question for your clinician — this post says that explicitly rather than blurring the line.
How we decide what to cover: the story has to be recent, traceable to a named source, and relevant to people who eat on a GLP-1. We skip the rumor layer entirely — if it cannot be linked, it does not get a page. That filter is the same one the site applies to food data, and it keeps the archive consistent over time.
The practical read of this story is simple: traceable sources and food data.
The plate does not change with the headline: protein anchors, vegetables fill, heavy food is portioned, water is constant.
Side-effect stories point to the two food levers — lower fat for nausea, more fiber plus water for constipation; outcome stories point to the same plate, day after day.
A headline is not a prescription: questions about your own dose or symptoms belong with your healthcare provider.
Small daily choices do not look like much alone; across the week they are the whole story. The week view is what makes that accumulation visible. The week also matches how the medication works, which is why the site keeps coming back to it.
Take the top of the protein list — chicken, fish, eggs, beans, the 20g+ per 100g foods — and make it the anchor. Fill half the plate with vegetables for fiber and volume, keep a small quarter for the food you actually want, and put the sauce on the side. That is the plate the data keeps producing, and every number in it is on the linked scored entry. It is the pattern the numbers endorse, not a fashion.
Weight plateau on a working dose is common; the food side is consistency, not severity, and the dose side is your clinician's territory. If a food fix works, great; if it does not, the next step is a conversation, not another food list.
Relevance is mostly indirect: a study changes which nutrient gets attention, not the food pattern itself. The pattern — protein first, portions small, fiber and water constant — survives every headline, and the criteria we publish are the reference for whichever nutrient the story highlights. Your dose and treatment questions remain your clinician's job.
No headline changes the data on this site. Food verdicts come from USDA values and guideline frameworks, not from any single story — a study can update the framework, but a single news cycle does not move the per-100g numbers. Patterns, not panic, are the response, and the pattern is the same plate: protein first, vegetables second, heavy food in small servings, water throughout.
Check the source, the date, and whether a named study or agency stands behind it — FDA, peer-reviewed journals such as JAMA and NEJM, and established health media. Beware of headlines that name no study and link to no source, and of stories that overstate a single trial. This post links its source openly; that is the same bar we hold ourselves to, and the same bar we suggest for anything you read.
Once a week is plenty for most people — the food pattern barely changes from headline to headline, and the site's verdicts are a stable reference. Daily checking mostly adds noise. When a headline genuinely affects your own medication or dose, that is the moment to involve your clinician rather than the news cycle.
Source: a news source · 2026-09-02. We link the original coverage and stay inside the food-relevant part of it, without restating unread details.
Every claim here can be walked back to a scoring sheet, a USDA value, or a named guideline. Everything here can be checked against a page on this site, and those pages are linked.
Side effects are the most common reason people pause a GLP-1, and the food levers are mostly the two this site scores: fat for nausea, fiber plus water for constipation. On a queasy day, the low-fat list is the reference; on a slow day, the high-fiber list. The symptom pages on the site group foods by exactly those levers, with the practical additions — small meals, dry and wet apart, cool food, sitting up after eating — spelled out. Persistent symptoms are still a conversation for your clinician.
When a GLP-1 story lands in the news, the question our readers ask is usually the same: does this change what
Eye doctors' consensus: GLP-1s may modestly raise rare…The headline first: 'Eye doctors' consensus: GLP-1s may modestly raise rare optic-nerve risk, bu
Low starter doses of GLP-1s still move the scale: 5.5% and…The headline first: 'Low starter doses of GLP-1s still move the scale: 5.5% and…', reported by a new